<description>&lt;p&gt;Interview with Colin P. Derdeyn, MD, author of Intravenous Argatroban or Eptifibatide in Patients Undergoing Mechanical Thrombectomy: A Subgroup Analysis of the MOST Randomized Clinical Trial. Hosted by Cynthia E. Armand, MD.&lt;br /&gt; &lt;br /&gt; &lt;strong&gt;Related Content:&lt;/strong&gt;&lt;/p&gt; &lt;ul&gt; &lt;li&gt;&lt;a class="related-article" href= "https://jamanetwork.com/journals/jamaneurology/fullarticle/10.1001/jamaneurol.2025.2794?utm_source=podcast_platforms&amp;utm_medium=referral&amp;utm_campaign=related_article_links" target="_blank" rel="noopener"&gt;Intravenous Argatroban or Eptifibatide in Patients Undergoing Mechanical Thrombectomy&lt;/a&gt;&lt;/li&gt; &lt;/ul&gt;</description>

JAMA Neurology Author Interviews

JAMA Network

Intravenous Argatroban or Eptifibatide and Mechanical Thrombectomy

AUG 18, 202519 MIN
JAMA Neurology Author Interviews

Intravenous Argatroban or Eptifibatide and Mechanical Thrombectomy

AUG 18, 202519 MIN

Description

Interview with Colin P. Derdeyn, MD, author of Intravenous Argatroban or Eptifibatide in Patients Undergoing Mechanical Thrombectomy: A Subgroup Analysis of the MOST Randomized Clinical Trial. Hosted by Cynthia E. Armand, MD. Related Content: